In these presentations from the 2020 Multidisciplinary Thyroid Symposium, Raja Seethala, MD, presents the latest updates in NIFTP thyroid pathology. Barry Schaitkin, MD, describes radioactive Iodine and its effect on salivary glands. Finally, Sally Carty, MD, FACS, explains the clinical utility of thyroid molecular testing.
Educational Objectives
Upon completion of this activity, participants should be able to:
- Recognize inclusion and exclusion criteria for NIFTP and implement recommended grossing procedures to facilitate diagnosis of NIFTP
- Implement reporting procedures for NIFTP based on WHO, CAP, and ICD-O-3 updates
- Describe how radioactive iodine effects the salivary gland and explain the symptoms that occur in patients after radioactive iodine
- Recall the role of salivary endoscopy in this patient population
- Identify the three specific types of investigation that sequentially test and vet a new clinical test
- Explain the clinical utility of molecular testing for thyroid follicular neoplasms managed under the current ATA guidelines
- Recognize the cost efficacy of thyroid molecular platforms for follicular neoplasm management compared to diagnostic surgery
Disclosures
Dr. Seethala has reported no relevant relationships with entities producing health care goods or services.
Dr. Schaikin has financial interests with the following entity or entities producing health care goods or services as indicated below:
- Consultant: Hood Laboratories
Dr. Carty has financial interests with the following entity or entities producing health care goods or services as indicated below:
- Royalties: UpToDate Inc. and Jaypee Brothers Inc.
- Grant/Research Support: William and Susan Johnson Fund for Endocrine Surgery Research
All presenters' disclosures of relevant financial relationships with any entity producing, marketing, re-selling, or distributing health care goods or services used on or consumed by patients is listed above. No other planners, members of the planning committee, speakers, presenters, authors, content reviewers, and/or anyone else in a position to control the content of this education activity have relevant financial relationships to disclose.
Accreditation Statement
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The University of Pittsburgh designates enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit[s]™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.
For your credit transcript, please access our website four weeks postcompletion at http://ccehs.upmc.com and follow the link to the Credit Transcript page.
Release Date: 3/11/2021 | Last Modified On: 3/11/2021 | Expires: 3/11/2022
